Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas

被引:14
作者
Estevez-Ordonez, Dagoberto [1 ]
Chagoya, Gustavo [1 ]
Salehani, Arsalaan [1 ]
Atchley, Travis J. [1 ]
Laskay, Nicholas M. B. [1 ]
Parr, Matthew S. [1 ]
Elsayed, Galal A. [1 ]
Mahavadi, Anil K. [1 ]
Rahm, Sage P. [1 ]
Friedman, Gregory K. [1 ,2 ]
Markert, James M. [3 ]
机构
[1] Univ Alabama Birmingham, Dept Neurosurg, 1060 Fac Off Tower 510 20th St South, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Pediat, Div Pediat Hematol Oncol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Neurosurg Neurosurg Pediat & Cell Dev & Inte, 1060 Fac Off Tower 510 20th St South, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
Glioblastoma; Immunovirotherapy; Oncolytic virus; Herpes simplex virus (HSV-1); Brain tumors; Oncolytic virotherapy; SIGNIFICANT ANTITUMOR-ACTIVITY; MEASLES-VIRUS STRAINS; PHASE-I TRIAL; CLINICAL-TRIAL; GENE-THERAPY; CHECKPOINT BLOCKADE; THYMIDINE KINASE; EXPRESSING IL-12; ONCOLYTIC VIRUS; REOVIRUS;
D O I
10.1016/j.nec.2020.12.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glioblastoma multiforme (GBM) represents one of the most challenging malignancies due to many factors including invasiveness, heterogeneity, and an immunosuppressive microenvironment. Current treatment modalities have resulted in only modest effect on outcomes. The development of viral vectors for oncolytic immunovirotherapy and targeted drug delivery represents a promising therapeutic prospect for GBM and other brain tumors. A host of genetically engineered viruses, herpes simplex virus, poliovirus, measles, and others, have been described and are at various stages of clinical development. Herein we provide a review of the advances and current state of oncolytic virotherapy for the targeted treatment of GBM and malignant gliomas. © 2021 Elsevier Inc.
引用
收藏
页码:265 / 281
页数:17
相关论文
共 131 条
[1]   Newcastle Disease Virus Interaction in Targeted Therapy against Proliferation and Invasion Pathways of Glioblastoma Multiforme [J].
Abdullah, Jafri Malin ;
Mustafa, Zulkifli ;
Ideris, Aini .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[2]   Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas [J].
Aboody, KS ;
Brown, A ;
Rainov, NG ;
Bower, KA ;
Liu, SX ;
Yang, W ;
Small, JE ;
Herrlinger, U ;
Ourednik, V ;
Black, PM ;
Breakefield, XO ;
Snyder, EY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12846-12851
[3]   Oncolytic measles virus strains have significant antitumor activity against glioma stem cells [J].
Allen, C. ;
Opyrchal, M. ;
Aderca, I. ;
Schroeder, M. A. ;
Sarkaria, J. N. ;
Domingo, E. ;
Federspiel, M. J. ;
Galanis, E. .
GENE THERAPY, 2013, 20 (04) :444-449
[4]   Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity [J].
Allen, Cory ;
Paraskevakou, Georgia ;
Iankov, Ianko ;
Giannini, Caterina ;
Schroeder, Mark ;
Sarkaria, Jann ;
Schroeder, Mark ;
Puri, Raj K. ;
Russell, Stephen J. ;
Galanis, Evanthia .
MOLECULAR THERAPY, 2008, 16 (09) :1556-1564
[5]   Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity [J].
Allen, Cory ;
Vongpunsawad, Sompong ;
Nakamura, Takafumi ;
James, C. David ;
Schroeder, Mark ;
Cattaneo, Roberto ;
Giannini, Caterina ;
Krempski, James ;
Peng, Kah-Whye ;
Goble, Jenny M. ;
Uhm, Joon H. ;
Russell, Stephen J. ;
Galanis, Evanthia .
CANCER RESEARCH, 2006, 66 (24) :11840-11850
[6]   The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors [J].
Andreansky, SS ;
He, B ;
Gillespie, GY ;
Soroceanu, L ;
Markert, J ;
Chou, J ;
Roizman, B ;
Whitley, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11313-11318
[7]   Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo [J].
Bai, Yang ;
Chen, Yong ;
Hong, Xinyu ;
Liu, Xinrui ;
Su, Xing ;
Li, Shanji ;
Dong, Xuechao ;
Zhao, Gang ;
Li, Yunqian .
SCIENTIFIC REPORTS, 2018, 8
[8]   Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy [J].
Belcaid, Zineb ;
Berrevoets, Cor ;
Choi, John ;
van Beelen, Edward ;
Stavrakaki, Eftychia ;
Pierson, Tessa ;
Kloezeman, Jenneke ;
Routkevitch, Denis ;
van der Kaaij, Marielle ;
van der Ploeg, Alicia ;
Mathios, Dimitrios ;
Sleijfer, Stefan ;
Dirven, Clemens ;
Lim, Michael ;
Debets, Reno ;
Lamfers, Martine L. M. .
NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
[9]   Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors [J].
Bernstock, Joshua D. ;
Bag, Asim K. ;
Fiveash, John ;
Kachurak, Kara ;
Elsayed, Galal ;
Chagoya, Gustavo ;
Gessler, Florian ;
Valdes, Pablo A. ;
Madan-Swain, Avi ;
Whitley, Richard ;
Markert, James M. ;
Gillespie, G. Yancey ;
Johnston, James M. ;
Friedman, Gregory K. .
HUMAN GENE THERAPY, 2020, 31 (19-20) :1132-1139
[10]   A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition [J].
Bernstock, Joshua D. ;
Vicario, Nunzio ;
Rong, Li ;
Valdes, Pablo A. ;
Choi, Bryan D. ;
Chen, Jason A. ;
DiToro, Daniel ;
Osorio, Diana S. ;
Kachurak, Kara ;
Gessler, Florian ;
Johnston, James M., Jr. ;
Atkinson, T. Prescott ;
Whitley, Richard J. ;
Bag, Asim K. ;
Gillespie, G. Yancey ;
Markert, James M. ;
Maric, Dragan ;
Friedman, Gregory K. .
ONCOIMMUNOLOGY, 2019, 8 (12)